2 Risky Coronavirus Vaccine Stocks That Could Make You Filthy Rich

Companies at the forefront of coronavirus vaccine research have been a veritable gold mine for investors this year. For example, shares of Moderna (NASDAQ: MRNA) have gained a staggering 278% over the first seven months of 2020, while Novavax's (NASDAQ: NVAX) stock has posted a healthy 3,500% return on investment during this same period. While Heat Biologics (NASDAQ: HTBX) and Vaxart (NASDAQ: VXRT) have both made quantum leaps in terms of their market caps this year, there's a strong chance that each of these lesser-known COVID-19 vaccine stocks may soon be gearing up for another jaw-dropping move higher.